Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies
Hollebecque, Antoine, Salvagni, Stefania, Plummer, Ruth, Niccoli, Patricia, Capdevila, Jaume, Curigliano, Giuseppe, Moreno, Victor, Braud, Filippo, Villambrosia, Sonia Gonzalez, Martin‐Romano, Patricia, Baudin, Eric, Arias, Marina, Alvaro, Juan, Parra‐Palau, Josep L., Sánchez‐Pérez, Tania, Aronchik, Ida, Filvaroff, Ellen H., Lamba, Manisha, Nikolova, Zariana, Bono, Johann S.
Published in Cancer (01.09.2022)
Published in Cancer (01.09.2022)
Get full text
Journal Article
Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma
Hollebecque, Antoine, Salvagni, Stefania, Plummer, Ruth, Isambert, Nicolas, Niccoli, Patricia, Capdevila, Jaume, Curigliano, Giuseppe, Moreno, Victor, Martin-Romano, Patricia, Baudin, Eric, Arias, Marina, Mora, Sheila, de Alvaro, Juan, Di Martino, Jorge, Parra-Palau, Josep L, Sánchez-Pérez, Tania, Aronchik, Ida, Filvaroff, Ellen H, Lamba, Manisha, Nikolova, Zariana, de Bono, Johann S
Published in Clinical cancer research (15.01.2021)
Published in Clinical cancer research (15.01.2021)
Get full text
Journal Article
The Mnks: MAP kinase-interacting kinases (MAP kinase signal-integrating kinases)
Buxade, Maria, Parra-Palau, Josep L, Proud, Christopher G
Published in Frontiers in bioscience (01.05.2008)
Published in Frontiers in bioscience (01.05.2008)
Get full text
Journal Article
Abstract 850: 32H2, a new diagnostic tool for HER2 CTFs
Palau, Josep L. Parra, Peg, Vicente, Escorihuela, Marta, Mancilla, Sandra, Arribas, Joaquín
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article